Intraday Trading Highlights
Shilpa Medicare Ltd opened the day with a notable gap up of 14.47%, setting a positive tone for the session. The stock maintained strong momentum throughout, touching its intraday peak at Rs 359.95. This surge represents a substantial outperformance compared to the Pharmaceuticals & Biotechnology sector, which the stock exceeded by 6.18% today.
Volatility was pronounced, with an intraday volatility of 5.32% calculated from the weighted average price, indicating active trading and price fluctuations. The stock’s price remains above its 5-day, 20-day, and 50-day moving averages, signalling short- to medium-term strength, although it continues to trade below its 100-day and 200-day moving averages.
Comparative Market Context
The broader market, represented by the Sensex, opened higher at 84,177.51 points, gaining 597.11 points or 0.71%. However, by the time of reporting, the Sensex was trading at 83,933.68, reflecting a modest gain of 0.42%. The index remains 2.65% shy of its 52-week high of 86,159.02. Despite trading below its 50-day moving average, the Sensex’s 50DMA remains above its 200DMA, indicating a generally positive medium-term trend. The index has recorded a three-week consecutive rise, gaining 2.94% over this period, with mega-cap stocks leading the advance.
In this environment, Shilpa Medicare Ltd’s 6.52% one-day gain significantly outpaced the Sensex’s 0.43% rise, underscoring the stock’s relative strength on the day.
Momentum building strong! This Mid Cap from NBFC is on our MomentumNow radar. Other investors are catching on – will you join?
- - Building momentum strength
- - Investor interest growing
- - Limited time advantage
Performance Trends Over Time
Examining Shilpa Medicare Ltd’s recent performance reveals a mixed but generally positive trend. Over the past week, the stock has surged 16.63%, far outpacing the Sensex’s 2.78% gain. The one-month performance also shows a strong 10.98% increase versus the Sensex’s 0.43%. However, the three-month and one-year figures reflect declines of 8.83% and 8.84% respectively, contrasting with the Sensex’s positive returns of 0.87% and 7.81% over the same periods.
Year-to-date, Shilpa Medicare Ltd has gained 4.28%, outperforming the Sensex’s negative 1.50% return. Over longer horizons, the stock’s three-year performance stands at an impressive 174.10%, significantly ahead of the Sensex’s 38.04%. The five-year and ten-year returns are 56.61% and 57.11% respectively, trailing the Sensex’s 63.53% and 249.44% gains over those periods.
Mojo Score and Market Capitalisation
Shilpa Medicare Ltd currently holds a Mojo Score of 40.0, with a Mojo Grade of Sell. This represents an upgrade from its previous Strong Sell grade, which was revised on 05 Feb 2026. The company’s market capitalisation grade stands at 3, reflecting its mid-cap status within the Pharmaceuticals & Biotechnology sector.
The stock’s upgrade in Mojo Grade suggests some improvement in underlying metrics, although the overall score remains cautious. The sector itself continues to be a focal point for investors, with Shilpa Medicare Ltd’s intraday strength highlighting its capacity for notable price movements within this context.
Trading Activity and Volatility
Today’s trading session was marked by high volatility and active volume, contributing to the stock’s sharp price movements. The gap-up opening at 14.47% set an aggressive tone, with the stock maintaining elevated levels throughout the day. The intraday volatility of 5.32% is indicative of significant price swings, which may reflect both profit-taking and fresh buying interest at various levels.
Technical indicators show the stock trading above its short-term moving averages, which often act as support levels during upward trends. However, the resistance posed by the 100-day and 200-day moving averages remains a factor to monitor in subsequent sessions.
Shilpa Medicare Ltd or something better? Our SwitchER feature analyzes this small-cap Pharmaceuticals & Biotechnology stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Sector and Market Positioning
Operating within the Pharmaceuticals & Biotechnology sector, Shilpa Medicare Ltd’s performance today stands out amid a market led by mega-cap stocks. While the Sensex’s gains were modest, the stock’s outperformance highlights its capacity to generate significant intraday returns. The sector’s dynamics, including regulatory developments and product pipelines, often contribute to such volatility and price action.
Despite the broader market’s cautious stance, Shilpa Medicare Ltd’s trading activity today underscores its relevance within the mid-cap space and its ability to attract focused trading interest.
Summary of Key Metrics
To summarise, Shilpa Medicare Ltd’s key intraday metrics on 09 Feb 2026 include:
- Day’s high: Rs 359.95 (14.47% gain)
- Opening gap up: 14.47%
- Intraday volatility: 5.32%
- Day change: 7.33%
- Outperformance vs sector: 6.18%
- Outperformance vs Sensex: 6.09% (6.52% vs 0.43%)
- Mojo Score: 40.0 (Grade: Sell, upgraded from Strong Sell on 05 Feb 2026)
- Market Cap Grade: 3 (Mid Cap)
These figures collectively illustrate a day of strong price appreciation and active trading for Shilpa Medicare Ltd, positioning it as a notable mover within its sector and the broader market.
Conclusion
Shilpa Medicare Ltd’s strong intraday performance on 09 Feb 2026, marked by a 7.33% gain and a day’s high of Rs 359.95, reflects significant market activity and volatility. The stock’s ability to outperform both its sector and the Sensex highlights its prominence in today’s trading session. While the Mojo Grade remains cautious, the recent upgrade and price action indicate evolving market dynamics for this mid-cap pharmaceutical player.
Unlock special upgrade rates for a limited period. Start Saving Now →
